Our aims for this initiative include helping EDs to:
On April 27th, 2021, HHS eliminated the mandatory 8-hour formal training requirement for physicians pursuing a federal DEA-X Waiver to treat up to 30 opioid use disorder (OUD) patients using evidence-based buprenorphine. Learn what it means for providers.
"Overdose deaths are spiking in the wake of COVID19. Outpatient addiction clinics are reducing hours and treatment facilities impacted by social distancing measures has meant limited capacity for those in need. There is one clear first step all providers can do to step up and address the #2epidemics facing our nation, get your DEA-X Waiver to give you the ability to treat addiction in an evidence based way."
Federal and State Regulations, Regulatory Considerations, and State Initiatives
Emergency Care and SUD during COVID-19
Drs. Nora Volkow & Gail D'Onofrio
The guidelines, measures, education and quality improvement activities and related data specifications developed by the American College of Emergency Physicians (ACEP) Emergency Quality Network are intended to facilitate quality improvement activities by physicians. The materials are intended to provide information and assist physicians in enhancing quality of care. The materials do not establish a standard of medical care, and have not been tested for all potential applications and therefore should not be used as a substitute for clinical or medical judgment. Materials are subject to review and may be revised or rescinded at any time by ACEP. The materials may not be altered without prior written approval from ACEP. The materials, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes (e.g., use by health care providers in connection with their practices).
Neither ACEP nor its members shall be responsible for any use of the materials or measures.
©2022 American College of Emergency Physicians. All rights reserved.